RESPONSE PENDING: Your Meeting with Tanushree Banerjee Tomorrow...
Here is the latest financial fact sheet of POLY MEDICURE. For more details, see the POLY MEDICURE quarterly results and POLY MEDICURE share price.
1 Day | % | 0.4 |
No. of shares | m | 95.97 |
1 Week | % | 4.8 |
1 Month | % | 5.5 |
1 Year | % | 69.4 |
52 week H/L | Rs | 1,727.0/945.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
POLY MEDICURE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 298 | 349 | 913 | 1,163 | 1,044 | |
Low | Rs | 176 | 167 | 207 | 689 | 652 | |
Sales per share (Unadj.) | Rs | 69.2 | 77.9 | 82.0 | 96.3 | 116.2 | |
Earnings per share (Unadj.) | Rs | 7.4 | 10.9 | 14.2 | 15.3 | 18.7 | |
Diluted earnings per share | Rs | 6.8 | 10.0 | 14.2 | 15.3 | 18.7 | |
Cash flow per share (Unadj.) | Rs | 11.6 | 15.5 | 19.1 | 20.9 | 24.6 | |
Dividends per share (Unadj.) | Rs | 2.00 | 2.00 | 2.50 | 2.50 | 3.00 | |
Adj. dividends per share | Rs | 1.84 | 1.84 | 2.50 | 2.50 | 3.00 | |
Avg Dividend yield | % | 0.8 | 0.8 | 0.4 | 0.3 | 0.4 | |
Book value per share (Unadj.) | Rs | 43.2 | 49.3 | 100.6 | 113.2 | 129.2 | |
Adj. book value per share | Rs | 39.7 | 45.3 | 100.5 | 113.2 | 129.1 | |
Shares outstanding (eoy) | m | 88.24 | 88.25 | 95.88 | 95.90 | 95.94 | |
Price / Sales ratio | x | 3.4 | 3.3 | 6.8 | 9.6 | 7.3 | |
Avg P/E ratio | x | 32.0 | 23.7 | 39.5 | 60.6 | 45.4 | |
P/CF ratio (eoy) | x | 20.4 | 16.7 | 29.3 | 44.3 | 34.4 | |
Price / Book Value ratio | x | 5.5 | 5.2 | 5.6 | 8.2 | 6.6 | |
Dividend payout | % | 27.0 | 18.4 | 17.6 | 16.4 | 16.1 | |
Avg Mkt Cap | Rs m | 20,928 | 22,763 | 53,703 | 88,782 | 81,394 | |
Total wages/salary | Rs m | 1,166 | 1,388 | 1,418 | 1,636 | 2,027 |
POLY MEDICURE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 6,108 | 6,872 | 7,865 | 9,231 | 11,152 | |
Other income | Rs m | 185 | 185 | 184 | 379 | 362 | |
Total revenues | Rs m | 6,293 | 7,057 | 8,049 | 9,610 | 11,514 | |
Gross profit | Rs m | 1,326 | 1,683 | 2,198 | 2,175 | 2,693 | |
Depreciation | Rs m | 373 | 405 | 475 | 540 | 572 | |
Interest | Rs m | 137 | 205 | 106 | 62 | 109 | |
Profit before tax | Rs m | 1,001 | 1,257 | 1,801 | 1,952 | 2,375 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 347 | 298 | 442 | 487 | 582 | |
Profit after tax | Rs m | 654 | 959 | 1,359 | 1,465 | 1,793 | |
Gross profit margin | % | 21.7 | 24.5 | 27.9 | 23.6 | 24.2 | |
Effective tax rate | % | 34.6 | 23.7 | 24.5 | 25.0 | 24.5 | |
Net profit margin | % | 10.7 | 14.0 | 17.3 | 15.9 | 16.1 |
POLY MEDICURE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 3,293 | 3,500 | 7,478 | 7,834 | 8,649 | |
Current liabilities | Rs m | 1,812 | 2,255 | 2,151 | 2,267 | 3,512 | |
Net working cap to sales | % | 24.2 | 18.1 | 67.7 | 60.3 | 46.1 | |
Current ratio | x | 1.8 | 1.6 | 3.5 | 3.5 | 2.5 | |
Inventory Days | Days | 18 | 41 | 194 | 158 | 57 | |
Debtors Days | Days | 767 | 675 | 723 | 817 | 771 | |
Net fixed assets | Rs m | 3,523 | 4,495 | 5,196 | 5,934 | 7,702 | |
Share capital | Rs m | 441 | 441 | 479 | 480 | 480 | |
"Free" reserves | Rs m | 3,370 | 3,906 | 9,168 | 10,380 | 11,914 | |
Net worth | Rs m | 3,811 | 4,347 | 9,648 | 10,860 | 12,393 | |
Long term debt | Rs m | 914 | 1,144 | 633 | 381 | 175 | |
Total assets | Rs m | 6,816 | 7,995 | 12,674 | 13,768 | 16,351 | |
Interest coverage | x | 8.3 | 7.1 | 17.9 | 32.7 | 22.9 | |
Debt to equity ratio | x | 0.2 | 0.3 | 0.1 | 0 | 0 | |
Sales to assets ratio | x | 0.9 | 0.9 | 0.6 | 0.7 | 0.7 | |
Return on assets | % | 11.6 | 14.6 | 11.6 | 11.1 | 11.6 | |
Return on equity | % | 17.2 | 22.1 | 14.1 | 13.5 | 14.5 | |
Return on capital | % | 24.1 | 26.6 | 18.5 | 17.9 | 19.8 | |
Exports to sales | % | 63.3 | 61.1 | 61.3 | 62.2 | 64.8 | |
Imports to sales | % | 25.4 | 28.0 | 26.9 | 28.1 | 35.6 | |
Exports (fob) | Rs m | 3,867 | 4,201 | 4,818 | 5,743 | 7,224 | |
Imports (cif) | Rs m | 1,554 | 1,925 | 2,116 | 2,595 | 3,975 | |
Fx inflow | Rs m | 3,867 | 4,201 | 4,818 | 5,743 | 7,224 | |
Fx outflow | Rs m | 1,554 | 1,925 | 2,116 | 2,595 | 3,975 | |
Net fx | Rs m | 2,313 | 2,275 | 2,702 | 3,148 | 3,249 |
POLY MEDICURE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,065 | 1,283 | 1,187 | 1,235 | 1,908 | |
From Investments | Rs m | -1,007 | -1,073 | -4,356 | -853 | -1,790 | |
From Financial Activity | Rs m | -51 | -205 | 3,169 | -353 | -125 | |
Net Cashflow | Rs m | 6 | 5 | 1 | 28 | -7 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Devendra Mehta | COMP SEC: Avinash Chandra | YEAR OF INC: 1995 | BSE CODE: 531768 | FV (Rs): 5 | DIV YIELD (%): 0.2 |
Read: POLY MEDICURE 2022-23 Annual Report Analysis
More Medical Equipment/supplies/accessories Company Fact Sheets: ADANI ENTERPRISES ADANI PORTS & SEZ ZOMATO APOLLO HOSPITALS ADANI TOTAL GAS
Compare POLY MEDICURE With: ADANI ENTERPRISES ADANI PORTS & SEZ ZOMATO APOLLO HOSPITALS ADANI TOTAL GAS
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.